Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Dermira Profit Margin 2013-2018 | DERM

Current and historical gross margin, operating margin and net profit margin for Dermira (DERM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Dermira net profit margin as of December 31, 2018 is -523.25%.
Dermira Annual Profit Margins
Dermira Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.745B $0.042B
Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases. Its late-stage product candidates comprise Cimzia which has completed Phase II clinical trials for the treatment of moderate-to-severe plaque psoriasis; DRM04 that is in a Phase IIb clinical trial for the treatment of hyperhidrosis or excessive sweating; and DRM01 which has completed a Phase IIa clinical trial for the treatment of acne. Dermira, Inc. is headquartered in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.886B 31.19
Takeda Pharmaceutical (TAK) Japan $32.435B 12.00
Grifols (GRFS) Spain $13.064B 15.83
Ionis Pharmaceuticals (IONS) United States $10.939B 33.92
Jazz Pharmaceuticals (JAZZ) Ireland $7.812B 11.19
Neurocrine Biosciences (NBIX) United States $7.728B 500.53
Sage Therapeutics (SAGE) United States $7.480B 0.00
Tilray (TLRY) United States $6.315B 0.00
Catalent (CTLT) United States $5.892B 24.67
Nektar Therapeutics (NKTR) United States $5.636B 8.99
United Therapeutics (UTHR) United States $5.259B 8.94
FibroGen (FGEN) United States $4.539B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.207B 13.54
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.128B 21.94
Zogenix (ZGNX) United States $2.204B 0.00
PTC Therapeutics (PTCT) United States $2.183B 0.00
Portola Pharmaceuticals (PTLA) United States $2.143B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.126B 0.00
Aerie Pharmaceuticals (AERI) United States $2.069B 0.00
USANA Health Sciences (USNA) United States $2.028B 17.01
Madrigal Pharmaceuticals (MDGL) United States $2.015B 0.00
Endo (ENDP) Ireland $1.854B 2.86
Enanta Pharmaceuticals (ENTA) United States $1.846B 22.99
Heron Therapeutics (HRTX) United States $1.810B 0.00
Xencor (XNCR) United States $1.735B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.702B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.566B 135.68
Theravance Biopharma (TBPH) Cayman Islands $1.288B 0.00
Corcept Therapeutics (CORT) United States $1.263B 18.35
TherapeuticsMD (TXMD) United States $1.208B 0.00
Esperion Therapeutics (ESPR) United States $1.117B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.088B 0.00
Tricida (TCDA) United States $0.974B 0.00
Radius Health (RDUS) United States $0.843B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.825B 0.00
ChemoCentryx (CCXI) United States $0.614B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.602B 0.00
GlycoMimetics (GLYC) United States $0.575B 0.00
Odonate Therapeutics (ODT) United States $0.569B 0.00
ArQule (ARQL) United States $0.541B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.538B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.528B 0.00
KalVista Pharmaceuticals (KALV) United States $0.508B 0.00
Collegium Pharmaceutical (COLL) United States $0.506B 0.00
Forty Seven (FTSV) United States $0.503B 0.00
Akebia Therapeutics (AKBA) United States $0.492B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.474B 27.93
Corbus Pharmaceuticals Holdings (CRBP) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.458B 0.00
Flexion Therapeutics (FLXN) United States $0.438B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.415B 0.00
Translate Bio (TBIO) United States $0.410B 0.00
OptiNose (OPTN) United States $0.394B 0.00
TCR2 THERAPTCS (TCRR) United States $0.388B 0.00
Aptorum Group (APM) China $0.379B 0.00
ImmunoGen (IMGN) United States $0.374B 0.00
Concert Pharmaceuticals (CNCE) United States $0.338B 0.00
Karyopharm Therapeutics (KPTI) United States $0.335B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.313B 11.60
Minerva Neurosciences (NERV) United States $0.303B 0.00
CASI Pharmaceuticals (CASI) United States $0.300B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.289B 0.00
Mast Therapeutics (SVRA) United States $0.287B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.285B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.282B 2.62
Xeris Pharmaceuticals (XERS) United States $0.267B 0.00
Majesco Entertainment (PTE) United States $0.261B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.254B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Calithera Biosciences (CALA) United States $0.248B 0.00
Aclaris Therapeutics (ACRS) United States $0.245B 0.00
HARPOON THERAPT (HARP) United States $0.244B 0.00
Dova Pharmaceuticals (DOVA) United States $0.242B 0.00
Opexa Therapeutics (ACER) United States $0.237B 0.00
ElectroCore (ECOR) United States $0.234B 0.00
Galectin Therapeutics (GALT) United States $0.215B 0.00
Tyme Technologies (TYME) United States $0.214B 0.00
MEI Pharma (MEIP) United States $0.212B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.207B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
Molecular Templates (MTEM) United States $0.202B 0.00
Jounce Therapeutics (JNCE) United States $0.202B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.201B 0.00
Rafael Holdings (RFL) United States $0.188B 0.00
IMV INC (IMV) Canada $0.188B 0.00
Aldeyra Therapeutics (ALDX) United States $0.187B 0.00
Redhill Biopharma (RDHL) Israel $0.187B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.185B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.182B 0.00
Aratana Therapeutics (PETX) United States $0.182B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 181.80
Ocular Therapeutix (OCUL) United States $0.170B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.158B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
Neon Therapeutics (NTGN) United States $0.146B 0.00
AgeX Therapeutics (AGE) United States $0.144B 0.00
China SXT Pharmaceuticals (SXTC) China $0.142B 0.00
Neos Therapeutics (NEOS) United States $0.142B 0.00
Recro Pharma (REPH) United States $0.141B 0.00
MediWound (MDWD) Israel $0.137B 0.00
ProNAi Therapeutics (SRRA) Canada $0.136B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.126B 0.00
Cardiome Pharma (CORV) Canada $0.118B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Iterum Therapeutics (ITRM) Ireland $0.112B 0.00
DURECT (DRRX) United States $0.111B 0.00
Adherex Technologies (FENC) United States $0.104B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.102B 0.00
Zafgen (ZFGN) United States $0.100B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.098B 0.00
Infinity Pharmaceuticals (INFI) United States $0.097B 0.00
Nivalis Therapeutics (ALPN) United States $0.094B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Avenue Therapeutics (ATXI) United States $0.091B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.086B 0.00
Otonomy (OTIC) United States $0.084B 0.00
India Globalization Capital (IGC) United States $0.082B 0.00
Natural Alternatives (NAII) United States $0.081B 7.92
SCYNEXIS (SCYX) United States $0.076B 0.00
Genocea Biosciences (GNCA) United States $0.069B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.065B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.062B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.058B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.056B 0.00
Forward Pharma (FWP) Denmark $0.055B 0.00
CTI BioPharma (CTIC) United States $0.054B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Lipocine (LPCN) United States $0.052B 0.00
Capnia (SLNO) United States $0.050B 0.00
KemPharm (KMPH) United States $0.050B 0.00
Bio-Path Holdings (BPTH) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
Melinta Therapeutics (MLNT) United States $0.042B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.037B 0.00
NOVAN INC (NOVN) United States $0.036B 0.00
ContraFect (CFRX) United States $0.036B 0.00
Achaogen (AKAO) United States $0.033B 0.00
HANCOCK JAFFE (HJLI) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Citius Pharmaceuticals (CTXR) United States $0.027B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.025B 0.00
IsoRay (ISR) United States $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Shineco (TYHT) China $0.023B 3.88
Biomerica (BMRA) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.022B 0.00
NanoViricides (NNVC) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.021B 0.00
Achieve Life Sciences (ACHV) United States $0.020B 0.00
Pain Therapeutics (PTIE) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
VAXART, INC (VXRT) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.011B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00